RI
NVO

Ridgewood Investments’s Novo Nordisk NVO Stock Holding History

Ridgewood Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$947K Buy
24,970
+3,602
+17% +$166K 0.35% 86
2026
Q2 		$1.02M Sell
21,368
-3,281
-13% -$141K 0.38% 85
2026
Q1 		$906K Buy
+24,649
New +$1.17M 0.37% 86
2025
Q3 		$519K Buy
9,346
+2,719
+41% +$159K 0.22% 125
2025
Q2 		$457K Buy
6,627
+4,457
+205% +$303K 0.2% 122
2025
Q1 		$151K Buy
2,170
+1,495
+221% +$123K 0.07% 206
2024
Q4 		$58.1K Buy
+675
New +$73K 0.03% 286
2023
Q3 		– Sell
-28
Closed -$2.27K – 566
2023
Q2 		$2.27K Hold
28
– – ﹤0.01% 690
2023
Q1 		$2.23K Buy
+28
New +$1.99K ﹤0.01% 679

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.31B AUM 12.25% 1-Year Est. Return

Ridgewood Investments's NVO Position: Q3 2026 in Review

Ridgewood Investments increased its Novo Nordisk (NVO) stake by 17% in Q3 2026, buying an estimated $166K and bringing the position to 24,970 shares worth $947K. The position accounts for 0.35% of the portfolio, ranked #86.

Ridgewood Investments first reported a position in NVO in Q1 2023 and has held it in 9 quarters since. The position peaked at $1.02M in Q2 2026. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Ridgewood Investments held 24,970 shares of Novo Nordisk worth $947K as of Q3 2026.
  • Ridgewood Investments bought 3,602 Novo Nordisk shares in Q3 2026, an estimated $166K.
  • Novo Nordisk made up 0.35% of Ridgewood Investments's portfolio in Q3 2026, its #86 holding.
  • Ridgewood Investments first reported a position in Novo Nordisk in Q1 2023 and has held it in 9 quarters since.
  • Ridgewood Investments's Novo Nordisk position peaked at $1.02M in Q2 2026.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Ridgewood Investments's 13F filing for Q3 2026, filed 5 Oct 2026.